
ConsumerBiotech & Life SciencesHealthcareAISaaSFintechE-Commerce & MarketplaceFood & AgricultureEducationManufacturing
Invus is a global investment firm headquartered in New York with offices in Paris, Hong Kong, and Singapore. Founded in 1985, it operates a continuous capital structure with over $10 billion under management, partnering with entrepreneurs across consumer, technology, and life sciences sectors from early-stage growth through public companies.
49% of their portfolio is in Biotech & Life Sciences. Deal activity increased 50% year-over-year (21 deals in the last 12 months). Average disclosed round size is $137.5M (across 185 rounds with reported amounts).
Portfolio
165
Fund Size
—
Top Stage
Series B
Last 12 Mo
21
Team
GP
Gretchen Piller
Managing Director
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
230 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | — | Oct 2026 | |
| Series D | $250M | Sep 2026 | |
| Series D | $89M | Sep 2026 | |
| Series F | $275M | Sep 2026 | |
| Series A | — | Sep 2026 | |
| LLupin Dental | Series A | — | Sep 2026 |
| LLifeMine | Series E | $188M | Aug 2026 |
| Series C | — | Jun 2026 | |
| Series D | $75M | Jun 2026 | |
| Series B | $99.5M | Jun 2026 | |
| Series C | — | Jun 2026 | |
| Series B | $125M | Apr 2026 | |
| CCorxel Pharmaceuticals Limited | Series D | $287M | Jan 2026 |
| Series B | $250M | Jan 2026 | |
| Series B | $250M | Jan 2026 | |
| Series F | $275M | Jan 2026 | |
| Series B | $80M | Jan 2026 | |
| EEncoded | Series F | $275M | Jan 2026 |
| Series B | $110M | Jan 2026 | |
| Series B | $120M | Dec 2025 | |
| Series D | $115M | Nov 2025 | |
| Series A | — | Nov 2025 | |
| HHemab | Series C | $157M | Oct 2025 |
| Series C | $60.3M | Oct 2025 | |
| Series C | — | Oct 2025 |
Page 1 of 10
Top Co-Investors
RA Capital Management41 shared
OrbiMed36 shared
ARCH Venture Partners32 shared
Polaris Partners28 shared
GV26 shared
Alexandria Venture Investments25 shared
Sofinnova Partners24 shared
Casdin Capital23 shared
Redmile Group23 shared
Perceptive Advisors20 shared
Boxer Capital18 shared
Fidelity Investments18 shared
Omega Funds15 shared
Deep Track Capital15 shared
Cormorant Asset Management15 shared
Samsara BioCapital15 shared
Surveyor Capital15 shared
Pfizer Ventures14 shared
Logos Capital14 shared
Last updated: 8 November 2026